Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FHL1 |
| Upstream (Parents) |
|---|
| (<<) HEG1 → FHL1 |
| (<<) FZD4 → FHL1 |
| (<<) ARHGEF6 → FHL1 |
| (<<) DCN → FHL1 |
| (<<) SPARCL1 → FHL1 |
| Downstream (Children) |
|---|
| FHL1 → HIPK3 (>>) |
| FHL1 → HSPB6 (>>) |
| FHL1 → DVL3 (>>) |
| FHL1 → GNRH2 (>>) |
| FHL1 → E2F4 (>>) |
| FHL1 → HSPB7 (>>) |
| FHL1 → PCDHA5 (>>) |
| FHL1 → ACTA1 (>>) |
| FHL1 → KBTBD10 (>>) |
| FHL1 → TTN (>>) |
| FHL1 → TPM2 (>>) |
| FHL1 → PYGM (>>) |
| FHL1 → MYLPF (>>) |
| FHL1 → TCAP (>>) |
| FHL1 → ATP1A2 (>>) |
| FHL1 → CASQ2 (>>) |
| FHL1 → CAPN3 (>>) |
| FHL1 → FAM48A///DES (>>) |
| FHL1 → GNAS (>>) |
| FHL1 → CCDC144A (>>) |
| FHL1 → HRC (>>) |
| FHL1 → ST20 (>>) |
| FHL1 → HDAC11 (>>) |
| FHL1 → LOC647070 (>>) |
| FHL1 → OR12D2 (>>) |
| FHL1 → CAP2 (>>) |
| FHL1 → LOC731884 (>>) |
| FHL1 → HSPB8 (>>) |
| FHL1 → ACTC1 (>>) |
